name,paper_title,publication_year,source
Lukasz S Wylezinski,Multiple sclerosis risk stratification and healthcare cost prediction using machine learning.,2025.0,PubMed
Jamieson D Gray,Multiple sclerosis risk stratification and healthcare cost prediction using machine learning.,2025.0,PubMed
Charles F Spurlock,Multiple sclerosis risk stratification and healthcare cost prediction using machine learning.,2025.0,PubMed
Shu-Chen Liao,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Ping-Jui Tsai,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Chang-Heng Liu,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Yung-Heng Hsu,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Ying-Chao Chou,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Yi-Hsun Yu,Pararectus vs. lateral window approach in AO B2.2 pelvic fractures: impact on short-term functional outcomes.,2025.0,PubMed
Feyisayo Olalere,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
Kiki van der Heijden,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
H Christiaan Stronks,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
Jeroen Briaire,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
Johan H M Frijns,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
Marcel van Gerven,Leveraging spatial cues from cochlear implant microphones to efficiently enhance speech separation in naturalistic listening scenes.,2025.0,PubMed
Ahmed Osman Ibrahim,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Azher M Abed,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Alisher Abduvokhidov,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Bekzod Madaminov,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Sanjarbek Madaminov,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Bharosh Kumar Yadav,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Nidhal Ben Khedher,A scenario based analysis of bidirectional electric vehicle-building integration for energy optimization and carbon emission reduction.,2025.0,PubMed
Yuquan Chu,STICformer: spatio-temporal intrinsic connections transformer for traffic flow prediction.,2025.0,PubMed
Tingting Fu,STICformer: spatio-temporal intrinsic connections transformer for traffic flow prediction.,2025.0,PubMed
Peng Liu,STICformer: spatio-temporal intrinsic connections transformer for traffic flow prediction.,2025.0,PubMed
Haksrun Lao,STICformer: spatio-temporal intrinsic connections transformer for traffic flow prediction.,2025.0,PubMed
Xiuchun Li,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Rebecca Hernandez,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Xudong Zhang,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Sijie Tang,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Xiaohong Yuan,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Jing Wu,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Kathy Pham,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Hukam C Rawal,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Erica C Heinrich,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Shenglong Zhang,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Qi Chen,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Tong Zhou,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Changcheng Zhou,A cholesterol-responsive hepatic tRNA-derived small RNA regulates cholesterol homeostasis and atherosclerosis development.,2025.0,PubMed
Zong-Xu Gao,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Chenyingchun Su,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Hai-Xia Zhang,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Yue-Qing Zhang,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Xiao-Xue Chen,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Xu-Yuan Liu,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Ai-Xia Cheng,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Ze-Jun Xu,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Hong-Xiang Lou,Divergent synthesis of Haplomitrium diterpenoids via a late-stage biomimetic skeletal reorganization approach.,2025.0,PubMed
Zhi-Xin Huang,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Yi-Ling Li,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Jian-Chao Peng,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Thanh-Tung Ho,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Hai Huang,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Michael Aschner,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Yue-Ming Jiang,"The Effects of Lead, Cadmium and Arsenic Exposure Alone or in Combination on Neurotoxicity Through Neural Signaling Pathways.",2025.0,PubMed
Yaqun Liu,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Lianghui Chen,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Xuanyi Zheng,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Peikui Yang,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Jinkun Han,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Jiayi Huang,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Yanling Shen,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Xiaotong Cai,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Miaofen Fang,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Yicun Chen,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Chengsong Xie,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Min Lin,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Yuzhong Zheng,The application of RPA-PfAgo technology combined with multidimensional data analysis in the rapid detection of the MTHFR A1298C polymorphism.,2025.0,PubMed
Christopher Reilly-Stitt,Laboratory Testing of Direct Oral Anticoagulants.,2025.0,PubMed
Xiaopeng Li,Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice.,2025.0,PubMed
Liang Wang,Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice.,2025.0,PubMed
Xiaoyu Cheng,Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice.,2025.0,PubMed
Ming Li,Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice.,2025.0,PubMed
Jiali Chen,Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice.,2025.0,PubMed
Athos Silva de Oliveira,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Sevan Alwan,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Philip T LoVerde,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Ramiz Shaheed,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Pranav Mandyam,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Rakesh Adhikari,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Peter Hotez,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Maria Elena Bottazzi,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Jeroen Pollet,mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.,2025.0,PubMed
Yan Huang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Shaoli Liu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Xiaoju Zhang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Bingxu Zhang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Feng Shi,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Jia Zhang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Shuaibo Shao,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Hongya Han,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Xiaoyun Ma,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Jing Xie,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Jianqi Zhang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Hongxiaoying Yu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Yongchao Zhao,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Jiazheng Jin,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Dong Xu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Liang Liu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Jianing Wang,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Yu Tan,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Kelu Xu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Lushuai Jin,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Quanjun Du,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Yifeng Geng,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Andong Liu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Wei Xu,Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma.,2025.0,PubMed
Zhaozheng Hou,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Ping Feng,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Chi-Leung Chiang,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Kazi Anisha Islam,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Songran Liu,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Ying Wang,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Yingpei Zhang,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Michael King-Yung Chung,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Ngar-Woon Kam,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Zilu Huang,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Victor Ho-Fun Lee,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Anne Wing-Mui Lee,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Dora Lai-Wan Kwong,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Wai Tong Ng,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Jason Wing Hon Wong,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Yunfei Xia,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Wei Dai,Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma.,2025.0,PubMed
Mousa Khalafi,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Saeid Fatolahi,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Michael E Symonds,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Sara K Rosenkranz,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Farnaz Dinizadeh,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Alexios Batrakoulis,"Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta-Analyses.",2025.0,PubMed
Qiang Ma,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Ryan F LeBouf,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Chengetayi Cornelius Rimayi,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Chol Seung Lim,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Desta Fekedulegn,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Ju-Hyeong Park,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Dale W Porter,Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.,2025.0,PubMed
Esraa Eloseily,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Ivanna Romankevych,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Taskin Sabit,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Lara Berklite,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Sarangarajan Ranganathan,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Paul Rosen,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Michael Henrickson,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Jennifer Huggins,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Grant Schulert,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Alexei Grom,Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.,2025.0,PubMed
Taylor Purzycki,Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.,2025.0,PubMed
Matthew Knapp,Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.,2025.0,PubMed
Shivangi Patel,Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.,2025.0,PubMed
V Menoury,Replacing hexane with 2-methyloxolane for defatting soybean meal fed to dairy cows: Effects on ruminal and milk fatty acid profiles and health indicators.,2025.0,PubMed
P Nozière,Replacing hexane with 2-methyloxolane for defatting soybean meal fed to dairy cows: Effects on ruminal and milk fatty acid profiles and health indicators.,2025.0,PubMed
C Delavaud,Replacing hexane with 2-methyloxolane for defatting soybean meal fed to dairy cows: Effects on ruminal and milk fatty acid profiles and health indicators.,2025.0,PubMed
Y Farizon,Replacing hexane with 2-methyloxolane for defatting soybean meal fed to dairy cows: Effects on ruminal and milk fatty acid profiles and health indicators.,2025.0,PubMed
A Ferlay,Replacing hexane with 2-methyloxolane for defatting soybean meal fed to dairy cows: Effects on ruminal and milk fatty acid profiles and health indicators.,2025.0,PubMed
Ying Liu,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Dandan Pan,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Pinyan Zhang,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Yuting Shao,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Yinhua Kong,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Zhenzhou Jiang,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Wenjing Zhu,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Houwen Wang,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Xinghan Liu,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Sitong Qian,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Tao Wang,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Xia Zhu,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Tingting Yang,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Qian Lu,Jujuboside A ameliorates glomerular podocytes lipotoxicity in diabetic mice by YY1-mediated promotion of intracellular cholesterol transport and efflux.,2025.0,PubMed
Nada F Abo El-Magd,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Nehal M Ramadan,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Yomna F Hassan,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Amr M Mahmoud,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Maha M Azzam,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Salma M Eraky,Ketogenic diet attenuates high fat diet induced obesity in rats: insights into hepatic and intestinal tissues.,2025.0,PubMed
Miguel Ganuza,HSC-independent and -dependent hematopoiesis: new insights and lineage tracing methods.,2025.0,PubMed
Momoko Yoshimoto,HSC-independent and -dependent hematopoiesis: new insights and lineage tracing methods.,2025.0,PubMed
Nidal A Qinna,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Bayan Y Ghanim,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Duaa Abu Arqoub,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Qasem Abdallah,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Malak Jaber,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Mohammad AlNatoor,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Duaa Sabbah,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Bayan Alkhawaja,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Dong-Hyun Kim,Effect of single binge alcohol consumption on alcohol-naïve and -exposed drinking mouse models.,2025.0,PubMed
Ian Strohbehn,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Anant D Bhave,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Joshua Kallen,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Geoffrey M Scriver,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Christopher S Morris,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Bill S Majdalany,GLP-1 receptor agonists and TIPS: A word of caution.,2025.0,PubMed
Jun Zhang,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Jintao Xuan,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Zheyun He,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Sijia Zhang,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Jing Zhou,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Hongliang Liu,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Zhanyang Xia,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Yuan Wu,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Si Chen,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Boming Wu,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Hongshan Li,Salidroside alleviates early-stage MASH through the PPARγ-mediated inflammatory signaling pathway.,2025.0,PubMed
Yudai Ohta,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Yohei Kanamori,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Ayato Maeda,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Mohamed Fathi Saleh,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Akihiro Nita,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Takashi Matsumoto,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Keiichi I Nakayama,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Toshiro Moroishi,Iron and bile acids synergize to exacerbate congenital cholestatic liver injury via ferroptosis.,2025.0,PubMed
Muhammad Bilal Habib,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Maryam Aftab,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Afreenish Amir,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Faheem Ullah,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Naseer Ali Shah,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Fatima Javed,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Nadhirah Mohamad Zain,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Aamer Ikram,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Muhammad Kamran,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Mamoon Ur Rasheed,Development and Characterization of Dual-Functional Polymeric Hydrogels: A Sustainable Approach for Drug Delivery and Antimicrobial Applications.,2025.0,PubMed
Russell Hunter,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Teresa Gluth,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Kate Seman,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Travis Goldsmith,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Riley Nett,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Victoria Nist,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Allison Dunn,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Eric Kelly,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Elizabeth Bowdridge,Persistent Impact of In Utero Nanoparticle Exposure on Metabolic and Endocrine Outcomes in Adult Rats Fed a High-Fat Diet.,2025.0,PubMed
Maria da Graça Landim Bravo,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Isadora de Jesus da Silva,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Nayara Fernanda Tokashike de Araújo,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Gabriel Neves Cezarette,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Ludmilla Tonani,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Marcia Regina von Zeska Kress,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Rodrigo De Vecchi,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Vanja Dakic,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Lorena Rigo Gaspar,Optimizing photopollution assessment: Insights from a reconstructed human epidermis model.,2025.0,PubMed
Shunsuke Koga,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Anjani Guda,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Yujie Wang,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Aarush Sahni,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Jiahui Wu,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Alyssa Rosen,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Jaxson Nield,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Nilan Nandish,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Krunal Patel,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Haviva Goldman,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Chamith S Rajapakse,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Selemon Walle,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Kristen Stashek,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Rashmi Tondon,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Zahra Alipour,Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.,2025.0,PubMed
Jeffrey V Lazarus,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Leire Agirre-Garrido,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Trenton M White,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Anish K Arora,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Melina I Manolas,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Luis Antonio Diaz,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Juan Pablo Arab,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Shira Zelber-Sagi,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Naim Alkhouri,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
C Wendy Spearman,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Jörn M Schattenberg,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Loreta A Kondili,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Patrizia Carrieri,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Holly F Lofton,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Priya Jaisinghani,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Sonal Kumar,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Ajay Duseja,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Mohamed El-Kassas,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Hirokazu Takahasi,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Debbie L Shawcross,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Jonathan G Stine,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Marcela Villota-Rivas,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Juan Emilio Miralles-Sanchez,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Silvana Pannain,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Paul N Brennan,Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.,2025.0,PubMed
Elsa Vazquez Arreola,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Qiuhong Gong,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Robert L Hanson,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Jinping Wang,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Leontine Sandforth,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Siyao He,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Arvid Sandforth,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Xin Qian,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Mauro Giacca,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Stefan R Bornstein,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Andreas Fritsche,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Norbert Stefan,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Hubert Preissl,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Edward W Gregg,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Nikolaus Marx,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Reiner Jumpertz-von Schwartzenberg,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Guangwei Li,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Andreas L Birkenfeld,Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.,2025.0,PubMed
Solvejg Wastvedt,Counterfactual fairness for small subgroups.,2024.0,PubMed
Jared D Huling,Counterfactual fairness for small subgroups.,2024.0,PubMed
Julian Wolfson,Counterfactual fairness for small subgroups.,2024.0,PubMed
Walter Knirsch,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Alexandra De Silvestro,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Celine Steger,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Verena Rathke,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Roland Weber,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Michael Von Rhein,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Juliane Schneider,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Damian Hutter,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Bettina Reich,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Ulrike Held,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Annette Hackenberg,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Ruth Tuura O'Gorman,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Raimund Kottke,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Andras Jakab,"Serial cerebral magnetic resonance imaging before and after birth in patients with complex congenital heart disease - a prospective, multicentre observational study.",2025.0,PubMed
Angelo Massaro,An,2025.0,PubMed
Cecilia Villegas-Novoa,An,2025.0,PubMed
Nancy Allbritton,An,2025.0,PubMed
Jiayin Huang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Jinyong Wang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Xinyu Wang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Weijian Yang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Hongfei Zhou,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Rongqi Cui,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Shiyi Zeng,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Rongrong Shao,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Ru Jin,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Ya Zhang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Xiaodong Wang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Wenxuan Zhong,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Weiwei Zhuang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Changqing Yang,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Xingjie Zan,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Yongping Chen,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Dazhi Chen,The mechanism of CISD3 regulating NRF2-ATP7B to ameliorate alcohol-induced liver mitochondrial dysfunction and cuproptosis.,2025.0,PubMed
Erin Jay G Feliciano,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Urvish Jain,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Edward Christopher Dee,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Aryan Selokar,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
J Richelyn Baclay,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
James Fan Wu,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Frances Dominique V Ho,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Bhav Jain,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Tej A Patel,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Nishwant Swami,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Kaisin Yee,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Kaitlyn Lapen,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Rod Carlo Columbres,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Navin Bhatt,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Adrian E Go,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Brandon S Imber,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Imjai Chitapanarux,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Frederic Ivan L Ting,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Douglas Tremblay,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Angelica Singh,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Damai Santosa,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Suporn Chuncharunee,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Gin-Gin Gan,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Nirmala Bhoo-Pathy,"Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts.",2025.0,PubMed
Qi Ruan,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Tao Chen,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Minwoo Kim,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Haotian Yang,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Debottam Sinha,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Yaowu He,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Lez Burke,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Lashith Wickramasuriya,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Lu Cao,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Weikang Yan,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
John Hooper,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Haolu Wang,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Kim Bridle,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Janin Chandra,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Darrell Crawford,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Xiaowen Liang,An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.,2025.0,PubMed
Claudia Mellenthin,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Fabien Schaller,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Lucie Vignot,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Sarah Peisl,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Rita Vesce,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Irene Esposito,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Carmen Gonelle-Gispert,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Cornelia Schneider,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Michel Adamina,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Leo Hans Bühler,IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study.,2025.0,PubMed
Peter J Skrdla,Probing the Meaning of the Constant ,2025.0,PubMed
Mohamed H Eldesouki,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Khaled Elfert,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Abdul-Rahman Abusalim,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Abdallfatah Abdallfatah,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Mohammed Abusuliman,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Mona A Ali,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Theodore Jr Dacosta,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Marc J Zuckerman,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Sherif E Elhanafi,Safety and Outcomes of Endoscopic and Radiologic Guided Placement of Percutaneous Gastrostomy Tube: A US Collaborative Network Study.,2025.0,PubMed
Leila Jafari Khouzani,Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.,2025.0,PubMed
Soroush Sardari,Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.,2025.0,PubMed
Soheila Jafari Khouzani,Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.,2025.0,PubMed
Horacio Pérez-Sánchez,Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.,2025.0,PubMed
Fahimeh Ghasemi,Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.,2025.0,PubMed
Chiara Stocchero,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Tommaso Manciulli,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Alessandro Zanon,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Gaspare Salvi,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Susanna A Sechi,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Alessia Pea,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Alessandra Cafiso,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Paola Pepe,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Ambra Vola,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Marcela A Cucher,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Enrico Brunetti,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Cristina Lecchi,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Chiara Bazzocchi,Detection of Echinococcus granulosus sensu lato microRNAs in cystic echinococcosis patients: An exploratory study using quantitative PCR and digital PCR.,2025.0,PubMed
Bibi Atika,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Sabrina Lehmann,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Elisa Buchberger,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Musa Dan'azumi Isah,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Zahra Basirkazerouni,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Michael Rostás,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Gregor Bucher,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Ernst A Wimmer,Genome-wide identification of genes involved in beetle odoriferous defensive stink gland function recognizes Laccase2 as the phenoloxidase responsible for toxic para-benzoquinone synthesis.,2025.0,PubMed
Haïzam Oubari,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Lucile Cabanel,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Yanis Berkane,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Loïc Van Dieren,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Barry L Bentley,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Maxime Jeljeli,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Mark A Randolph,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Basak E Uygun,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Korkut Uygun,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Curtis L Cetrulo,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Alexandre G Lellouch,Establishing a Swine Model to Study Whole Eye Transplant Dynamic Preservation and Transplantation.,2025.0,PubMed
Peter M Barrett,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Aisling Jennings,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Heike Roth,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Molly Byrne,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Emma Wallace,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Amanda Henry,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Fergus P McCarthy,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Karolina Kublickiene,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Ali S Khashan,"""You just forget about preeclampsia and move on"" -awareness of chronic disease risks and follow-up preferences after preeclampsia in Ireland: a national qualitative study.",2025.0,PubMed
Roberto A Ribas,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Franca Bucco Paolasso,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Alison M Ryan,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Manuel R Sanchez,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Charles M Soto,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Scarlett I Caffee,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Reece C Larson,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Derek B Allison,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Matthew S Gentry,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Ramon C Sun,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Craig W Vander Kooi,Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.,2025.0,PubMed
Anne-Fleur Griffon,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Loeïza Rault,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Clément Tanvet,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Etienne Simon-Lorière,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Myrielle Dupont-Rouzeyrol,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Catherine Inizan,Development of a competition assay to assess the in vitro fitness of dengue virus serotypes using an optimized serotype-specific qRT-PCR.,2025.0,PubMed
Stephen Coleman,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Lisa Breckels,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Ross F Waller,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Kathryn S Lilley,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Chris Wallace,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Oliver M Crook,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Paul D W Kirk,Semi-supervised Bayesian integration of multiple spatial proteomics datasets.,2025.0,PubMed
Torbjørn V Ness,Predicting neural responses to intra- and extra-cranial electric brain stimulation by means of the reciprocity theorem.,2025.0,PubMed
Christof Koch,Predicting neural responses to intra- and extra-cranial electric brain stimulation by means of the reciprocity theorem.,2025.0,PubMed
Gaute T Einevoll,Predicting neural responses to intra- and extra-cranial electric brain stimulation by means of the reciprocity theorem.,2025.0,PubMed
Ramya Melepattu Valappil Kuttappan,Protective effect of antioxidant triterpenes of ,2025.0,PubMed
Steffy Dennis,Protective effect of antioxidant triterpenes of ,2025.0,PubMed
Sruthi Panniyan Kandyil,Protective effect of antioxidant triterpenes of ,2025.0,PubMed
Reghunathan Muthuswamy,Protective effect of antioxidant triterpenes of ,2025.0,PubMed
Achuthan C Raghavamenon,Protective effect of antioxidant triterpenes of ,2025.0,PubMed
Xin Yang,Primary Pulmonary Osteosarcoma Presenting as a 1.7-cm Subpleural Nodule in a 61-Year-Old Man: A Case Report.,2025.0,PubMed
Wen Guang Zhao,Primary Pulmonary Osteosarcoma Presenting as a 1.7-cm Subpleural Nodule in a 61-Year-Old Man: A Case Report.,2025.0,PubMed
Chao Gao,Primary Pulmonary Osteosarcoma Presenting as a 1.7-cm Subpleural Nodule in a 61-Year-Old Man: A Case Report.,2025.0,PubMed
Sheng Lin,Primary Pulmonary Osteosarcoma Presenting as a 1.7-cm Subpleural Nodule in a 61-Year-Old Man: A Case Report.,2025.0,PubMed
Hatice Demir,Investigation of Clinical and Laboratory Findings of 40-49-Year-Old Patients with Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).,2025.0,PubMed
Salim Tece,Investigation of Clinical and Laboratory Findings of 40-49-Year-Old Patients with Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).,2025.0,PubMed
Hasan Yigit,Investigation of Clinical and Laboratory Findings of 40-49-Year-Old Patients with Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).,2025.0,PubMed
Levent Filik,Investigation of Clinical and Laboratory Findings of 40-49-Year-Old Patients with Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).,2025.0,PubMed
Daoyuan Xie,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Yu Tian,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Fan Zheng,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Lianying Wu,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Guofeng Xu,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Qinghua Liu,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Guanting Lu,Multi-Omics and Integrative Analytics in Natural Products Discovery.,2025.0,PubMed
Stephanie Michelin Santana Pereira,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Vinícius Parzanini Brilhante de São José,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Lívya Alves Oliveira,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Kelly Aparecida Dias,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Lívia Carvalho Sette Abrantes,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Ceres Mattos Della Lucia,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Elad Tako,Impact of anthocyanin-rich fruits on the modulation of inflammation and oxidative stress in the gut-liver axis: a systematic review of ,2025.0,PubMed
Matteo Clemot,Topological Autoencoders++: Fast and Accurate Cycle-Aware Dimensionality Reduction.,2025.0,PubMed
Julie Digne,Topological Autoencoders++: Fast and Accurate Cycle-Aware Dimensionality Reduction.,2025.0,PubMed
Julien Tierny,Topological Autoencoders++: Fast and Accurate Cycle-Aware Dimensionality Reduction.,2025.0,PubMed
Samineh Beheshtirouy,Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.,2025.0,PubMed
Zeinab Nikniaz,Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.,2025.0,PubMed
Saba Ghaffary,Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.,2025.0,PubMed
Raha Jaberi,Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.,2025.0,PubMed
Elnaz Shaseb,Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.,2025.0,PubMed
Brian A Cahn,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Runze Zhang,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Allie M Sidwell,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Christie Mena Adam,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Jessica Tiv,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Rowanne Murrar,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Jessica Koh,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Tina Griffin,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Umer Nadir,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Michael D Yi,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Areeba Ahmed,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Melissa Ma,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Eric Koza,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Misha Haq,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Victoria Shi,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Allen E Bale,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Jesse M Lewin,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Sean R Christensen,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Abigail Waldman,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Christopher B Harmon,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Addy Alt-Holland,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Lisa M Arkin,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Jamin C Morrison,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Kathleen Bogart,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Michael D Gregory,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Mary E Lohman,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Anthony Rossi,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Ashfaq A Marghoob,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Leonard Goldberg,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
S Brian Jiang,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Cerrene N Giordano,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Jennifer N Choi,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Joyce M C Teng,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Bharat B Mittal,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Allison T Vidimos,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
David J Leffell,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Yaohui Gloria Xu,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Roger Haber,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Paul A Storrs,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Maria Tsoukas,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Faramarz H Samie,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
David R Bickers,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Kishwer S Nehal,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Klara Mosterd,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Elizabeth M Billingsley,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Ervin H Epstein,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Dirk Elston,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Murad Alam,Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome.,2025.0,PubMed
Seth D Tyler,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Hamsa Priya Bhuchakra,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
James Kim,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Shahab Ahmadzadeh,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Varsha Allampalli,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Sahar Shekoohi,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Alaa Abd-Elsayed,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Alan D Kaye,Efficacy of Combined Suprascapular Block and Axillary Nerve Block for Post-Operative Pain Management in Shoulder Arthroplasty: A Narrative Review.,2025.0,PubMed
Zailin Fu,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Xia Zhan,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Min He,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Zhijun Dong,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Yuanyuan Fang,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Xiaoying Zhang,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Ting Zhou,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Bo Jin,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Dabu Zhu,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Jianrong Gu,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Yi Zhou,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Yifang Chen,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Minghua Xie,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Hong Yuan,Beyond existing rating scales: development of a novel nomogram for predicting severe clinical bleeding associated with low-molecular-weight heparin in hospitalized medical patients.,2025.0,PubMed
Alan D Kaye,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Austin S Thomassen,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Camille B Coreil,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Raheem H Kazmi,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Judy N Vu,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Ellie M MacDonald,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Kylie D Dufrene,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Shahab Ahmadzadeh,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Daniel Bass,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Saurabh Kataria,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Sahar Shekoohi,Efficacy and Emerging Role of Erector Spinae Plane Block for Pain Management during Labor.,2025.0,PubMed
Alan D Kaye,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Alexia J Enache,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Grace C Wester,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Landyn Johnson,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Megan Gremillion,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Austin S Thomassen,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Shahab Ahmadzadeh,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Sonja A Gennuso,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Joseph Drinkard,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Sahar Shekoohi,Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.,2025.0,PubMed
Fatima Alaba Mohammed,Antidiabetic Activity of Amaranthus hybridus Leaf-based Diet in High-fat Diet and Streptozotocin-induced Diabetic Rats.,2025.0,PubMed
Rukayat Abiodun Oyegoke,Antidiabetic Activity of Amaranthus hybridus Leaf-based Diet in High-fat Diet and Streptozotocin-induced Diabetic Rats.,2025.0,PubMed
Adenike Temidayo Oladiji,Antidiabetic Activity of Amaranthus hybridus Leaf-based Diet in High-fat Diet and Streptozotocin-induced Diabetic Rats.,2025.0,PubMed
Adedoyin Igunnu,Antidiabetic Activity of Amaranthus hybridus Leaf-based Diet in High-fat Diet and Streptozotocin-induced Diabetic Rats.,2025.0,PubMed
Jeffrey O'Callaghan,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Natalie Hudson,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Nicole Hanley,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Avril Reddy,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Aisling Naylor,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Alan Hopkins,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Matthew O'Riordan,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Fionn O'Leary,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Deirdre Harford,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Rory Holohan,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Denis Nevrov,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Eleanor Demmons,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Matthew S Lawrence,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Sarah L Doyle,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Peter D Westenskow,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Mark Cahill,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Matthew Campbell,Automated Assessment of Retinal Vascular Integrity Across Species.,2025.0,PubMed
Constance Bertrand,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Idir Ouzaid,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Felix Guerrero-Ramos,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Gautier Marcq,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
John P Sfakianos,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Evanguelos Xylinas,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Pierre-Etienne Gabriel,A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives.,2025.0,PubMed
Brianna C Theriault,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Paul Serrato,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Shaila D Ghanekar,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Shashank Rajkumar,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Avani DiLuna,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Omar Allam,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Michael Alperovich,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Michael DiLuna,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Aladine A Elsamadicy,Utilizing Machine Learning to Predict Perioperative Blood Transfusion in Pediatric Craniosynostosis Patients Undergoing Cranial Vault Remodeling.,,PubMed
Gianfranca Stornaiuolo,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Mariantonietta Pisaturo,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Lorenzo Salmoni,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Antonio Russo,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Debora Angrisani,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Giovanni Valente,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Francesco Longobardi,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Antonella Santonicola,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Filomena Morisco,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Maria Stanzione,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Alfonso Galeota Lanza,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Rosaria Focareta,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Caterina Sagnelli,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Carmine Coppola,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Nicola Coppola,Impact of HDV infection on post-transplant outcomes in patients transplanted for HBV-related liver disease: results from a multicenter cohort study in Southern Italy.,2025.0,PubMed
Sushil Kumar Yadav,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Tapas Kumar Dutta,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Anupam Chatterjee,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Asif Mohammad,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Sneha Dutta,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Dilip Kumar Mandal,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Partha Das,Arsenic-induced oxidative damages and toxicity in young goats: potential mitigation with vitamin E and phytogenic feed additives.,2025.0,PubMed
Alan D Kaye,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Jasmine J Fagan,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Austin S Thomassen,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Leon C LaHaye,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Gabrielle A Cassagne,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Anna Ardoin,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Charles J Fox,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Shahab Ahmadzadeh,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Michael Heisler,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Joseph Drinkard,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Sahar Shekoohi,The Efficacy and Safety of Serratus Anterior Plane Block for Pain Management in Patients with Rib Fractures: a Narrative Review.,2025.0,PubMed
Chu-Chu Zhang,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Jun-Yue Zhang,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Ying Liu,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Xiao-Xi Wang,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
De-Qiang Gao,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Ze-Hui Chen,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Yi Liu,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Hong-Sheng Lin,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Hai-Yan Li,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Jia-Bin Zheng,Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.,2025.0,PubMed
Matthew B Bratton,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Humza A Pirzadah,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Michael J Starns,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Rahib K Islam,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Sahar Shekoohi,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Alaa Abd-Elsayed,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Alan D Kaye,"Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review.",2025.0,PubMed
Yating Fan,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Xiangshuai Gu,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Hua Yang,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Ye Chen,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Chao Fang,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Hongxin Deng,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Lei Dai,Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.,2025.0,PubMed
Pan Zhou,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Qiuhong Wu,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Guang Fan,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Zhiwen Yang,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Songsong Bao,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Jin Li,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Xiaofei Yang,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Xinyue Liu,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Fangzhou Jing,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Li Jiang,The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).,2025.0,PubMed
Reham H Mohyeldin,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Ehab E Sharata,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Mahmoud Abdelnaser,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Mina Ezzat Attya,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Al Shaimaa Mahmoud Kotb,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Remon Roshdy Rofaeil,Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.,2025.0,PubMed
Giuseppe Loggia,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Aron Alakmeh,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Fedan Avrumova,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Franziska C S Altorfer,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Jiaqi Zhu,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Frank P Cammisa,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Andrew Sama,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Mazda Farshad,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Darren R Lebl,Accuracy of Augmented Reality Navigation Versus Freehand Pedicle Screw Placement.,2025.0,PubMed
Aadi Zaragoza-Jiménez,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Luis Fernando López-Lara,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Evelyn Dennis Álvarez-Velázquez,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Raúl Santiago Aceves-Enríquez,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
José Francisco Muñoz-Valle,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Jorge Hernandez-Bello,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Mauricio Andrés Salinas-Santander,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Alba Adriana Vallejo-Cardona,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Clara Patricia Rios-Ibarra,Liposomal nanomedicine in Cancer therapy: advances in drug delivery.,2025.0,PubMed
Jérôme Foucaud,Challenges and prospects for research into health promotion in schools and the fight against cancers.,2025.0,PubMed
Carine Simar,Challenges and prospects for research into health promotion in schools and the fight against cancers.,2025.0,PubMed
Anne-Fleur Guillemin,Challenges and prospects for research into health promotion in schools and the fight against cancers.,2025.0,PubMed
Chantal Vandoorne,Challenges and prospects for research into health promotion in schools and the fight against cancers.,2025.0,PubMed
Sylvain Gautier,Challenges and prospects for research into health promotion in schools and the fight against cancers.,2025.0,PubMed
Suzanne Laberge,Implemented to last? Schools' strategies for promoting the sustainability of the '60 minutes a day of physical activity' initiative in Quebec primary schools.,2025.0,PubMed
Véronique Gosselin,Implemented to last? Schools' strategies for promoting the sustainability of the '60 minutes a day of physical activity' initiative in Quebec primary schools.,2025.0,PubMed
Lili Bao,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Keying Li,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Yue Fan,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Zhen Ge,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Yang Zeng,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Tian Xia,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Qicheng Zhang,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Si Pan,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Wenhui Chen,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Haimeng Yin,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Bo You,Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.,2025.0,PubMed
Ingrid Berling,The effect of decontamination and elimination in large acute lithium overdoses.,2025.0,PubMed
Geoffrey K Isbister,The effect of decontamination and elimination in large acute lithium overdoses.,2025.0,PubMed
Rowan Haffner,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Brian Mathew,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Francesco Brigo,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Anila Qasim,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Victoria San Antonio-Arce,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Houda Ben Ayed,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Edoardo Ferlazzo,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Churl-Su Kwon,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Kheng Seang Lim,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
James W Mitchell,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Muhammad A Salisu,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Kette Valente,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Kollencheri Puthenveettil Vinayan,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Colin B Josephson,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Nathalie Jette,Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.,2025.0,PubMed
Lindsay M Squeglia,Fostering Long-Term International Collaborations Through Short-Term Exchange Programs for Early Career Addiction Researchers.,2025.0,PubMed
Louise Mewton,Fostering Long-Term International Collaborations Through Short-Term Exchange Programs for Early Career Addiction Researchers.,2025.0,PubMed
Eisha Pandey,,2025.0,PubMed
Shivani Mishra,,2025.0,PubMed
Aastha Varshney,,2025.0,PubMed
Saman Habib,,2025.0,PubMed
Satish Mishra,,2025.0,PubMed
Svetlana Karamycheva,Spatial-temporal genome analysis and its application for the prediction of functional systems in bacteria and archaea.,2025.0,PubMed
Yuri I Wolf,Spatial-temporal genome analysis and its application for the prediction of functional systems in bacteria and archaea.,2025.0,PubMed
Eugene V Koonin,Spatial-temporal genome analysis and its application for the prediction of functional systems in bacteria and archaea.,2025.0,PubMed
Kira S Makarova,Spatial-temporal genome analysis and its application for the prediction of functional systems in bacteria and archaea.,2025.0,PubMed
Clémence David,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Nadia Nathan,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Eslam Al-Abadi,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Peter D Arkwright,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Brigitte Bader-Meunier,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Sebastian Becker,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Alexandre Belot,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Mary Brennan,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Sylvain Breton,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Vincent Bondet,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Jacques Cadranel,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Aurore Coulomb l'Hermine,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Sébastien De Almeida,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Darragh Duffy,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Teresa Clavaguera Poch,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Alix de Becdelièvre,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Siham El Khalifi-Boulisfane,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Marco Gattorno,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Montse Gispert-Saüch,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Florian Gothe,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Yves Hatchuel,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Daniela Herdliczko,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Ayse Ayzit Kilinc,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Vaclav Koucky,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Géraldine Labouret,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Raffaele Manna,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Hélène Maillard,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
María Luisa Matoses Ruipérez,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Caterina Matucci-Cerinic,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Anna Mensa-Vilaro,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Katarzyna Michel,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Thierry Jo Molina,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Berta Lopez Montesinos,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
William G Newman,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Julia Papenkort,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Christina Rapp,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Cinthia Rames,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Gillian I Rice,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Markus A Rose,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Heloise Reumaux,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Laurent Sailler,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Nicolaus Schwerk,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Luis Seabra,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Jérémie Sellam,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Andrea Taddio,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Caroline Thumerelle,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Alberto Tommasini,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Maud Tusseau,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Stefano Volpi,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Martin Wetzke,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Laurence Weiss,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Anne Welfringer-Morin,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Marie Wislez,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Matthias Griese,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Yanick J Crow,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Marie-Louise Frémond,Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.,2025.0,PubMed
Abdeali Saif Arif Kaderi,The Concept of Anatomical Analogy Between the Liver and the Pancreas.,2025.0,PubMed
Poornima Aiswarya Munagala,The Concept of Anatomical Analogy Between the Liver and the Pancreas.,2025.0,PubMed
Vasileios K Mavroeidis,The Concept of Anatomical Analogy Between the Liver and the Pancreas.,2025.0,PubMed
Andrew MacCormick,The Concept of Anatomical Analogy Between the Liver and the Pancreas.,2025.0,PubMed
Somaiah Aroori,The Concept of Anatomical Analogy Between the Liver and the Pancreas.,2025.0,PubMed
Jens Tidemandsen,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Vibeke Backer,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Anne Sophie Homøe,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Thomas H L Jensen,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Kasper Aanæs,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Howraman Meteran,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Morten Hostrup,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Lukas Moesgaard,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Christiane Haase,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Peter G Gibson,The Global Airways in Practice: Long-term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP.,2025.0,PubMed
Sarah Daniels,A single session online training reduces intolerance of uncertainty and improves mental health in emerging adults.,2025.0,PubMed
Yasmin Hasan,A single session online training reduces intolerance of uncertainty and improves mental health in emerging adults.,2025.0,PubMed
Susanne Schweizer,A single session online training reduces intolerance of uncertainty and improves mental health in emerging adults.,2025.0,PubMed
Nyla Bent,"EXPRESS: Primary Portal Vein Hypoplasia in Cats: Clinical Findings, Diagnosis, and Outcomes in Five Cases.",2025.0,PubMed
Shawn Kearns,"EXPRESS: Primary Portal Vein Hypoplasia in Cats: Clinical Findings, Diagnosis, and Outcomes in Five Cases.",2025.0,PubMed
Pamela Mouser,"EXPRESS: Primary Portal Vein Hypoplasia in Cats: Clinical Findings, Diagnosis, and Outcomes in Five Cases.",2025.0,PubMed
Patty Ewing,"EXPRESS: Primary Portal Vein Hypoplasia in Cats: Clinical Findings, Diagnosis, and Outcomes in Five Cases.",2025.0,PubMed
Chenxi Li,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Mingxin Lin,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Min Zhu,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Jianmin Lin,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Xiujuan Li,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Huiming Ye,Differential Functions of Membrane-bound and Soluble TNF-α in Regulating Trophoblasts Invasion and Migration.,2025.0,PubMed
Shilpi Pathak,Unveiling Indazole: Novel Synthetic Pathways and Biological Potentials.,2025.0,PubMed
Anmol Goswami,Unveiling Indazole: Novel Synthetic Pathways and Biological Potentials.,2025.0,PubMed
Kenika Sharma,Unveiling Indazole: Novel Synthetic Pathways and Biological Potentials.,2025.0,PubMed
Wei Zhang,,2025.0,PubMed
Linlin Zhou,,2025.0,PubMed
Xinyuan Huang,,2025.0,PubMed
Xinning Zhao,,2025.0,PubMed
Wenqing Bo,,2025.0,PubMed
Dongbei Guo,,2025.0,PubMed
Xiaoxuan Chen,,2025.0,PubMed
Lili Pan,,2025.0,PubMed
Hongwei Li,,2025.0,PubMed
Xueqin Liu,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Ling Chen,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Yunfeng Chen,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Yanmei Huang,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Xinhua Xiao,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Xiaolin Zhong,Insulin-like growth factor 2 alleviates metabolic inflammation and associated cognitive impairment in diet-induced obesity mice.,2025.0,PubMed
Shiping Zeng,Case Report: Nursing strategies for colon cancer surgery in third-trimester pregnancy.,2025.0,PubMed
Jiayou Chen,Case Report: Nursing strategies for colon cancer surgery in third-trimester pregnancy.,2025.0,PubMed
Yan Luo,Case Report: Nursing strategies for colon cancer surgery in third-trimester pregnancy.,2025.0,PubMed
Dan Song,Case Report: Nursing strategies for colon cancer surgery in third-trimester pregnancy.,2025.0,PubMed
Ameya Joshi,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Natasha Ratnapradipa,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Jayce Hughes,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Erik Moore,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Andrew Ekpenyong,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Surabhi Shukla,Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an ,2025.0,PubMed
Megumi Mizushima,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Masakazu Abe,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Yusuke Todo,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Toshiya Itoh,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Megumi Narumi,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Madoka Matsuya,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Toshiaki Shibata,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Hirotake Murakami,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Hiroaki Itoh,Hemostasis and life-saving by arterial embolization for a rupture of hepatic metastasis from choriocarcinoma after initiation of EMA/CO therapy: a case report and literature review.,2025.0,PubMed
Egor Shitikov,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Maja Malakhova,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Sofya Kuznetsova,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Dmitry Bespiatykh,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Roman Gorodnichev,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Sergei Kiselev,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Maria Kornienko,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Ksenia Klimina,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Aleksandra Strokach,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Arina German,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Anastasiia Lebedeva,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Mikhail Fursov,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Anna Vnukova,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Dmitry Bagrov,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Anastasia Kazyulina,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Margarita Shleeva,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Marina Zaychikova,Mycobacteriophage Yasnaya_Polyana and its engineered lytic derivative: specificity of regulatory motifs and lytic potential.,2025.0,PubMed
Mario Iza-Arteaga,,2025.0,PubMed
Verónica Lira-Ruan,,2025.0,PubMed
Edgar Balcázar-López,,2025.0,PubMed
Jorge Luis Folch-Mallol,,2025.0,PubMed
Ayixon Sánchez-Reyes,,2025.0,PubMed
Yejin Son,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Peisheng He,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Mathew Baldwin,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Guangyu Li,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Zijian Wang,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
April Z Gu,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Jenny Kao-Kniffin,Geno-pheno characterization of crop rhizospheres: an integrated Raman spectroscopy and microbiome approach in conventional and organic agriculture.,2025.0,PubMed
Hujiaabudula Buweialiye,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
Luyuan Guo,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
Jinqiao Yue,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
Runda Jie,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
Chaoyang Ding,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
Guixia Wu,Integrated network pharmacology and experimental validation reveal ,2025.0,PubMed
